Introduction: New scores have been developed and validated in the US for in-hospital mortality risk stratification in patients undergoing coronary angioplasty: the National Cardiovascular Data Registry (NCDR) risk score and the Mayo Clinic Risk Score (MCRS). We sought to validate these scores in a European population with acute coronary syndrome (ACS) and to compare their predictive accuracy with that of the GRACE risk score. Methods: In a single-center ACS registry of patients undergoing coronary angioplasty, we used the area under the receiver operating characteristic curve (AUC), a graphical representation of observed vs. expected mortality, and net reclassification improvement (NRI)/integrated discrimination improvement (IDI) analysis to compare the scores. Results: A total of 2148 consecutive patients were included, mean age 63 years (SD 13), 74% male and 71% with ST-segment elevation ACS. In-hospital mortality was 4.5%. The GRACE score showed the best AUC (0.94, 95% CI 0.91---0.96) compared with NCDR (0.87, 95% CI 0.83---0.91, p=0.0003) and MCRS (0.85, 95% CI 0.81---0.90, p=0.0003). In model calibration analysis, GRACE showed the best predictive power. With GRACE, patients were more often correctly classified than with MCRS (NRI 78.7, 95% CI 59.6---97.7; IDI 0.136, 95% CI 0.073---0.199) or NCDR (NRI 79.2, 95% CI 60.2---98.2; IDI 0.148, 95% CI 0.087---0.209). Conclusion: The NCDR and Mayo Clinic risk scores are useful for risk stratification of in-hospital mortality in a European population of patients with ACS undergoing coronary angioplasty. However, the GRACE score is still to be preferred. (NRI 78,7, IC 95% 59,7; IDI 0,136, IC 95% 0,199) e NCDR (NRI 79,2, IC 95% 60,2 ---98,2; IDI 0,148, IC 95% 0,087 ---0,209). Conclusão: Os scores NCDR e MC são úteis na estratificação de risco para mortalidade hospitalar numa população europeia de doentes com SCA submetidos a angioplastia coronária. Contudo, o score GRACE continua a ser o ideal.
PALAVRAS-CHAVE